drugset / Trial / NCT02600715
Reduction of Bladder Injection Pain With Belladonna Opiate Suppository
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to test whether using belladonna \& opiate suppositories (B\&Os) can improve patient discomfort during Onabotulinumtoxin A (BoNT) injection into the bladder for treatment of overactive bladder, neurogenic detrusor overactivity, or interstitial cystitis.
Timeline
- Start
- 2015-11
- Primary completion
- 2017-06-26
- Completion
- 2017-06-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Belladonna | Unknown | 16.2 mg | — |
| Subject | Morphine | Other / unclassified | 7.5 mg | — |
| Background | Botulinum toxin type A | Protein / enzyme biologic | — | — |